$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
万赛维用量和体重有关系吗?
2025-10-19 11:44:20
Check Details
万赛维用法用量?
2025-10-19 11:44:20
Check Details
万赛维什么时候吃效果最好?
2025-10-19 11:44:20
Check Details
万赛维能预防巨细胞病毒感染吗?
2025-10-19 11:44:20
Check Details
新药!Prevymis预防高危肾移植患者CMV感染疗效显著!
2025-10-19 11:44:20
Check Details
马利巴韦FDA和EMA双获批,治疗移植受者耐药性巨细胞病毒感染
2025-10-19 11:44:20
Check Details
马利巴韦是什么药?
2025-10-19 11:44:20
Check Details
马利巴韦如何使用?
2025-10-19 11:44:20
Check Details
怎么辨别莱特莫韦真假?
2025-10-19 11:44:20
Check Details
来特莫韦和更昔洛韦有什么区别?
2025-10-19 11:44:20
Check Details
“突围刺客”来特莫韦击溃“移植巨魔”——将巨细胞病毒扼杀在摇篮!
2025-10-19 11:44:20
Check Details
马立巴韦治疗巨细胞病毒感染的疗效?
2025-10-19 11:44:20
Check Details
1
2
...
4216
4217
4218
4219
4220
4221
4222
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Daraxonrasib Pregnancy, Lactation and Contraception Safety
2
Afatinib Side Effects and Safety Management
3
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
4
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis
5
Key points for drug monitoring of Molotinib in bone marrow fibrosis
6
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
7
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
8
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
9
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
10
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
11
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
12
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring